ENGINEERED CHIMERIC FUSION PROTEIN COMPOSITIONS AND METHODS OF USE THEREOF - Patent 3962497

(19)

(11)

EP 3 962 497 A1

(12)

(43)	Date of publication:
	09.03.2022 Bulletin 2022/10

(21)	Application number: 20798060.8

(22)	Date of filing: 30.04.2020

(51)

International Patent Classification (IPC):

A61K 35/15^(2015.01)

(52)	Cooperative Patent Classification (CPC):
	A61K 35/15; A61K 31/7088; A61K 38/19; A61K 9/0019; C07K 2319/03; C07K 2317/622; C07K 16/2896; C07K 16/32; C07K 2319/033; A61K 2039/5156; A61K 39/001106; A61K 39/001129; C07K 14/7051

	C-Sets:
	A61K 38/19, A61K 2300/00;

(86)	International application number:
	PCT/US2020/030837

(87)	International publication number:
	WO 2020/223550 (05.11.2020 Gazette 2020/45)

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
	Designated Extension States:
	BA ME
	Designated Validation States:
	KH MA MD TN

(30)

Priority:

30.04.2019 US 201962841190 P
30.04.2019 US 201962841183 P
23.03.2020 US 202016827381
23.03.2020 US 202016827302

(71)	Applicant: Myeloid Therapeutics, Inc.
	Boston, MA 02199 (US)

(72)	Inventors:
	GETTS, Daniel Boston, Massachusetts 02199 (US) WANG, Yuxiao Boston, Massachusetts 02199 (US)

(74)	Representative: Brand Murray Fuller LLP
	50 Eastcastle Street London W1W 8EA London W1W 8EA (GB)

(54)	ENGINEERED CHIMERIC FUSION PROTEIN COMPOSITIONS AND METHODS OF USE THEREOF